This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **Michael E. Boulton: Innovator in Gene Therapy**
Introduction
Michael E. Boulton, located in Chelsea, Alabama, is a prominent inventor in the field of biotechnology. He holds a significant patent pertaining to rAAV vector compositions and their applications in treating type I diabetes. His work focuses on innovative methods of targeting vascular endothelial cells, showcasing the potential for advancing gene therapy techniques.
Latest Patents
Boulton's notable patent involves capsid-modified recombinant Adeno-Associated Virus (rAAV) expression vectors. This invention includes infectious virions, compositions, and pharmaceutical formulations that utilize these vectors. The patent outlines methods for preparing and employing these novel capsid-protein-mutated rAAV constructs in various diagnostic and therapeutic applications. It specifically addresses their role in the delivery for treatment and diagnosis of disorders related to the mammalian vascular system, particularly complications arising from type I diabetes.
Career Highlights
Michael E. Boulton is associated with the University of Florida Research Foundation, Incorporated, where he contributes to vital research in gene therapy and biotechnology. His pioneering work has the potential to influence the medical field significantly, particularly in treatments relating to vasculitis and complications from type I diabetes, such as diabetic retinopathy and nephropathy.
Collaborations
Throughout his career, Boulton has collaborated with esteemed colleagues, including William W. Hauswirth and Sanford Leon Boye. These collaborations enhance the depth and scope of his research, contributing to advancements in the application of genetic therapies.
Conclusion
Michael E. Boulton stands out as an innovative inventor dedicated to improving gene therapy methods. His work underlines the importance of targeted therapeutic approaches, especially concerning vascular health and diabetes treatment. Through his patents and collaborations, he continues to impact the biomedical field profoundly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile